{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:52:43Z","timestamp":1769579563085,"version":"3.49.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:p>We read with great interest the article by Buttars et al. (Clin Exp Dermatol 2025; 50:1035\u20137) on drug-induced psoriasis from second-generation androgen receptor blockers. We report two additional cases that reinforce this association and underscore the importance of recognizing this adverse reaction.<\/jats:p>","DOI":"10.1093\/ced\/llaf480","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T12:52:03Z","timestamp":1762692723000},"page":"321-323","source":"Crossref","is-referenced-by-count":1,"title":["Comment on \u2018Two cases of drug-induced psoriasis from second-generation androgen receptor blockers\u2019 and two additional cases supporting an emerging drug reaction"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-1821","authenticated-orcid":false,"given":"Maria Clara","family":"De Angeli","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Soares Silv\u00e9rio","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Pladevall","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1959-4908","authenticated-orcid":false,"given":"Denis","family":"Miyashiro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Cury-Martins","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Sanches","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"2026012711322606500_llaf480-B1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ced\/llae509","article-title":"Two cases of drug-induced psoriasis from second-generation androgen receptor blockers","volume":"50","author":"Buttars","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026012711322606500_llaf480-B2","doi-asserted-by":"crossref","first-page":"adv00659","DOI":"10.2340\/actadv.v102.858","article-title":"Psoriatic skin lesions after apalutamide treatment","volume":"102","author":"Miyagawa","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"2026012711322606500_llaf480-B3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1272\/jnms.JNMS.2022_89-503","article-title":"Maculopapular drug eruption caused by apalutamide: case report and review of the literature","volume":"89","author":"Katayama","year":"2022","journal-title":"J Nippon Med Sch"},{"key":"2026012711322606500_llaf480-B4","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.1400076","article-title":"Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis","volume":"194","author":"Schwinge","year":"2015","journal-title":"J Immunol"},{"key":"2026012711322606500_llaf480-B5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/TCRM.S175244","article-title":"No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study","volume":"14","author":"Liu","year":"2018","journal-title":"Ther Clin Risk Manag"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf480\/65268746\/llaf480.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/321\/65268746\/llaf480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/321\/65268746\/llaf480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:32:37Z","timestamp":1769531557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/2\/321\/8320426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,23]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf480","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,23]]}}}